MedPath
TGA Approval

STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial (420571)

420571

STEQEYMA ustekinumab 130 mg/26 mL concentrate for solution for infusion vial

Celltrion Healthcare Australia Pty Ltd

September 11, 2024

Medicine

Medicine

Active

Registered

Product Information

Product Information

https://medical-cdn.nocode.com/drug_tga/25405731d7c41ee504824da14769b99c.pdf

Active Ingredients

Ustekinumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.